It’s not something that anyone wants to prepare for, but that doesn’t make it any less important. Since the “War on Cancer” began, we have invested over $4 trillion in finding a cure, but to date have only managed to extend life expectancy by around 3.3 years. Cancer costs US employers around $150 billion per year, and around 30% of patients diagnosed with cancer suffer serious financial hardship. Early diagnosis is the best chance of survival, and that’s where employers can play a crucial role.
Join us for a free webinar with Darren Rowe, Chief Innovation Officer at Wamberg Genomic Advisors, leading provider of affordable access to advanced genetic testing and dedicated support services that can enhance cancer prevention and survival for employees. He’ll take an informative look at why cancer is so difficult to treat, why it demands its own solution and how to create a world-class management strategy at your organization.

Darren Rowe

Chief Innovation Officer, Wamberg Genomics Advisors

A co-founder and former CEO of the UK’s largest independent cancer navigation company, Darren is WGA’s Chief Innovation Officer, with leadership responsibility for strategic innovation and program design. Darren has a career background in the biotechnology, pharmaceutical and healthcare industries, and has held several leadership roles within companies specializing in the development of disruptive and innovative genomic technologies for personalized cancer treatments. Darren and his family recently relocated to the USA from London, UK.